/
Cardiovascular
Congestive Heart Failure
15
Pipeline Programs↗
7
Active Trials↗
25
Companies Involved↗
Congestive Heart Failure is an emerging landscape with 15 programs across 25 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
Preclinical15
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Modality Breakdown
93%
Small molecule
13 of 14 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 14 classified programs, each share of the total. Modality classified for 100% of 15 pipeline programs.
Analysis
Trial Status
98
clinical trials
Completed58 · 59%
Terminated17 · 17%
Unknown status8 · 8%
Withdrawn7 · 7%
Recruiting4 · 4%
Not yet recruiting2 · 2%
Other2 · 2%
Clinical Trials
Trial Activity
98 trials
Page 1 of 7
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)